Answer: A positive fFN test signals higher preterm labor risk and prompts monitoring or treatment; a negative result indicates low risk and prenatal care.
By Shubhra Mishra — a mom of two who turned her own confusion during pregnancy into BumpBites, a global mission to make food choices clear, safe, and stress-free for every expecting mother. 💛
Check whether any food is safe during pregnancy with the BumpBites Food Safety Checker.
Download the Complete Pregnancy Food Guide (10,000 Foods) 📘
Instant PDF download • No spam • Trusted by thousands of moms
💡 Your email is 100% safe — no spam ever.
Quick take: A fetal fibronectin (fFN) test helps estimate your short‑term risk of preterm labor, but it isn’t a crystal ball. A positive result means the protein was detected and your risk is higher, while a negative result usually indicates a low chance of delivering within the next two weeks. Regardless of the outcome, your care team will tailor monitoring, lifestyle advice, and, if needed, medical interventions to keep you and baby safe.
It’s 2 a.m., you’ve just felt a tightening in your belly and the thought “Is this preterm labor?” races through my mind. You scroll, you read, and you land on a page that promises an answer about that strange lab result you received: “fFN positive.” You’re not alone—many expecting parents wonder what a fetal fibronectin test really tells them and what they should do next.
In this guide we’ll walk through what preterm labor is, why the fFN test is used, how to read the numbers, and what concrete steps you can take whether the test is positive or negative. We’ll also cover how the test fits into overall prenatal care, lifestyle tweaks that may lower your risk, and the red‑flag signs that mean you should call your provider right away. By the end you’ll have a clear roadmap, so the next time you see a result, you’ll know exactly what it means for you and your baby.
What is preterm labor and why it matters
Preterm labor is the onset of regular uterine contractions that cause cervical change before 37 weeks of gestation. When labor starts early, the baby may be born before its organs have fully matured, increasing the risk of respiratory distress, feeding difficulties, and long‑term neurodevelopmental challenges. According to the World Health Organization (WHO), preterm birth accounts for roughly 15 % of all deliveries worldwide and is the leading cause of neonatal mortality.
Most women who experience preterm labor have no obvious warning signs, but certain factors raise the odds: prior preterm birth, multiple gestation, uterine anomalies, infections, smoking, and chronic health conditions such as hypertension or diabetes. Recognizing these risk factors early lets clinicians intervene—sometimes with medication, sometimes with closer monitoring—to buy precious weeks for fetal growth.
Because the window between a warning sign and an actual birth can be short, clinicians rely on tools like the fetal fibronectin (fFN) test to stratify risk. Knowing where you stand helps your provider decide whether to keep you under routine observation or to step up care with steroids, tocolytics, or additional testing.
Beyond the immediate medical concerns, preterm birth also has emotional and financial impacts. Families may face prolonged NICU stays, additional follow‑up appointments, and increased anxiety about long‑term outcomes. Early risk identification, therefore, serves both clinical and psychosocial goals, allowing families to plan and seek supportive resources sooner rather than later.
Late‑night worries about a test result are common—but understanding the numbers can bring peace of mind.
How does the fetal fibronectin (fFN) test work?
Fetal fibronectin is a protein that acts like a “glue” between the fetal membranes and the uterine lining. In a healthy pregnancy, it’s typically present in the cervix early on, disappears by the second trimester, and reappears only when the membranes begin to separate—a sign that labor may be approaching.
During the test, a clinician gently swabs the vaginal canal (or sometimes the cervix) with a sterile applicator. The sample is then analyzed in a lab or with a bedside rapid assay. If fFN is detected at ≥ 50 ng/mL, the result is reported as “positive.” If the level is below that threshold, it’s “negative.” Some labs also provide a quantitative value, which can be useful for tracking changes over time.
Because the test is non‑invasive, inexpensive, and can be performed in an office setting, it’s become a go‑to tool for women who present with symptoms such as uterine tightening, pelvic pressure, or vaginal spotting between 22 and 34 weeks of gestation. The test is not recommended after 35 weeks because the predictive value drops as the body naturally prepares for birth.
In addition to the swab, many clinics use a rapid point‑of‑care cartridge that delivers results within minutes, allowing the provider to discuss next steps while you’re still in the exam room. This immediacy can reduce anxiety and streamline care, especially when an urgent decision about steroids or tocolytics is needed.
Tip: The swab should be taken before a digital exam or after a brief period without intercourse, as recommended by the Royal College of Obstetricians and Gynaecologists (RCOG), to avoid contaminating the sample.
The rapid fFN assay provides results within minutes, helping providers act quickly.
Interpreting fFN test results: positive, negative, and borderline
A positive fFN result means the protein was found above the detection limit. This does not guarantee that labor will start within the next two weeks, but it does raise the short‑term risk substantially. In practice, a positive result can increase the estimated probability of preterm delivery from about 2 % (baseline) to roughly 15–20 %.
A negative fFN result is reassuring. Studies cited by the American College of Obstetricians and Gynecologists (ACOG) show that a negative test carries a negative predictive value of about 98 % for delivery within 14 days. In other words, it’s very unlikely you’ll go into preterm labor in the immediate two‑week window, though it does not eliminate the overall lifetime risk of preterm birth.
Some labs report a “borderline” or “indeterminate” range (e.g., 30–50 ng/mL). In these cases, clinicians often repeat the test in 24–48 hours or combine the result with other clinical findings—like cervical length measured by transvaginal ultrasound—to refine risk assessment.
It’s also worth noting that the test’s interpretation can differ slightly depending on the laboratory’s assay and the gestational age at which it’s performed. Always ask your provider which assay was used and whether the result includes a quantitative value, as this information can guide follow‑up decisions.
Key point: A borderline result should never be ignored; it signals the need for close observation and possibly a repeat test, especially if symptoms persist.
How accurate is the fFN test?
The fFN test is valued for its high negative predictive value, but its positive predictive value is modest. A meta‑analysis referenced by the National Institute for Health and Care Excellence (NICE) reports:
Metric
Typical Range
Sensitivity (detecting true positives)
80 % – 85 %
Specificity (detecting true negatives)
90 % – 95 %
Negative Predictive Value
≈ 98 % for delivery within 14 days
Positive Predictive Value
≈ 15 % – 20 % for delivery within 14 days
What this means is that a negative result is a strong “rule‑out” for imminent preterm labor, while a positive result signals enough risk to warrant closer surveillance and possibly preventive treatment. The test’s performance is best when done between 22 and 34 weeks, in women who have symptoms but no obvious cervical change.
Accuracy can also be influenced by how the sample is collected. Contamination with blood or mucus can lead to false‑positive results, which is why clinicians are trained to obtain the specimen under sterile conditions and may repeat the test if the first result is unexpected.
Finally, the test should always be interpreted in the context of your overall clinical picture—risk factors, symptoms, and ultrasound findings. When combined with cervical length measurement, the predictive accuracy improves, reducing both false‑positive and false‑negative rates.
Clinical tip: The NHS advises that a negative fFN result should still be paired with continued symptom monitoring for at least 48 hours.
Next steps after a positive fFN result
If your test comes back positive, your provider will likely implement a “tiered” plan:
Confirm symptoms and cervical status. A quick pelvic exam or transvaginal ultrasound will assess cervical length. A short cervix (≤ 25 mm) combined with a positive fFN heightens the urgency.
Administer antenatal corticosteroids. According to ACOG, a single course of betamethasone or dexamethasone can accelerate fetal lung maturity, reducing the risk of respiratory distress if delivery occurs before 34 weeks.
Consider tocolytic therapy. Medications such as nifedipine or atosiban may be used to delay labor for 48 hours, providing a window for steroids to work and for the mother to be transferred to a higher‑level facility if needed.
Increase monitoring frequency. You might be asked to attend weekly or even twice‑weekly visits, with repeat fFN testing or ultrasound checks to track any changes.
Discuss lifestyle modifications. While the test itself doesn’t change diet, stress, or activity recommendations, your provider will emphasize smoking cessation, adequate hydration, and avoiding heavy lifting or strenuous exercise.
Plan for delivery. In some cases, a planned early‑term delivery (e.g., 36 weeks) may be discussed if the risk of spontaneous preterm birth remains high despite interventions.
Throughout this process, it helps to have a clear record of your results. If you’d like to keep track of your own numbers, try the Fetal Fibronectin (fFN) calculator, which lets you log dates, values, and any follow‑up actions.
In addition to medical steps, many women find comfort in a “preterm birth preparedness kit” that includes a list of hospital contacts, a copy of their birth plan, and a small bag of personal items. Having this kit ready can reduce anxiety if an unexpected admission occurs.
Quick reminder: Even after a positive result, many pregnancies continue to full term when appropriate interventions are started promptly.
Managing risk after a negative fFN result
A negative result is reassuring, but it doesn’t mean you can ignore other risk factors. Your provider will still advise standard prenatal care, which includes:
Regular prenatal visits and routine ultrasounds to monitor growth.
Screening for infections such as bacterial vaginosis or urinary tract infections, which can trigger preterm labor.
Maintaining optimal nutrition—adequate protein, iron, calcium, and omega‑3 fatty acids—to support fetal development.
Stress‑reduction techniques, like prenatal yoga, breathing exercises, or guided meditation, which have been shown to lower cortisol levels.
Avoiding known triggers: smoking, illicit drugs, excessive caffeine (> 300 mg/day), and high‑impact sports.
Even with a negative fFN, staying vigilant for new symptoms (e.g., sudden pelvic pressure, fluid leakage, or vaginal bleeding) is essential. If anything changes, contact your care team promptly.
Some clinicians also recommend a “watchful waiting” approach for the next two weeks, during which you keep a symptom diary and limit activities that could increase intra‑abdominal pressure. This proactive stance can catch early warning signs before they evolve into full‑blown labor.
Note from NHS guidance: Women with a negative fFN result should still be advised to avoid strenuous activity for at least 24 hours after testing.
Role of fFN testing in prenatal care timeline
The fFN test isn’t a routine screening for every pregnancy. Instead, it’s a targeted tool used when you present with symptoms that could herald preterm labor, typically between 22 and 34 weeks. Here’s a quick timeline:
First trimester (0‑13 weeks): No fFN testing; focus on early prenatal vitamins and confirming dates.
Second trimester (14‑27 weeks): Routine anatomy scan; if you develop symptoms after 22 weeks, your provider may order an fFN test.
Early third trimester (28‑34 weeks): The sweet spot for fFN testing. Positive results trigger interventions; negative results reassure but still require routine care.
Late third trimester (35‑36 weeks): The test’s predictive value wanes; clinicians rely more on cervical length and clinical judgment.
Because the test is most informative when used at the right moment, it’s helpful to discuss any concerning symptoms as soon as they arise, rather than waiting for a scheduled visit.
When the fFN test is part of a broader assessment—including blood work, infection screens, and ultrasound findings—it becomes a piece of a comprehensive risk‑stratification puzzle, allowing for individualized care plans.
Good nutrition supports overall pregnancy health, complementing any medical interventions you may need.
Understanding cervical length ultrasound and its synergy with fFN
Transvaginal cervical length measurement is a short ultrasound that visualizes how long the cervix is in millimeters. A cervix longer than 30 mm is generally considered low risk, while a length of 25 mm or less signals a higher chance of preterm birth. When combined with a positive fFN result, a short cervix dramatically increases the probability of delivery within two weeks, prompting more aggressive management.
Research from the Society for Maternal‑Fetal Medicine (SMFM) shows that the dual‑test approach (fFN + cervical length) improves the overall predictive accuracy to about 90 % for identifying women who will deliver preterm. This means fewer unnecessary interventions for low‑risk women and more timely treatment for those at genuine risk.
If your provider orders a cervical length scan after a positive fFN, the procedure typically takes less than five minutes and does not require a full bladder. Results are often available immediately, allowing the clinician to discuss next steps while you’re still in the office.
Practical tip: Schedule the ultrasound on the same day as the fFN test when possible; many clinics coordinate the two to reduce travel and anxiety.
Lifestyle and self‑care strategies after an fFN test
Whether your result is positive or negative, lifestyle choices still play a crucial role in supporting a healthy pregnancy. Here are evidence‑backed habits that can help reduce the chance of preterm labor:
Stay hydrated. Aim for at least 8‑10 cups of water daily. Dehydration can increase uterine irritability.
Eat a balanced diet. Focus on lean proteins, whole grains, leafy greens, and omega‑3‑rich foods like salmon or walnuts. These nutrients support fetal brain development and maternal immune function.
Get moderate exercise. Low‑impact activities such as walking, swimming, or prenatal yoga improve circulation and reduce stress without over‑exerting the uterus.
Prioritize sleep. Aim for 7‑9 hours of restful sleep each night. Use pillows for side‑lying comfort, and keep the bedroom cool and dark.
Practice stress‑management. Mindfulness meditation, breathing exercises, or a short daily gratitude journal can lower cortisol, which has been linked to preterm labor risk.
Avoid heavy lifting. Limit activities that require you to lift more than 10 pounds, and use proper body mechanics when you must lift.
For mothers who experience anxiety after a positive result, a brief referral to a perinatal mental‑health specialist can be beneficial. Studies in the NHS indicate that counseling and peer support groups reduce stress levels and improve pregnancy outcomes.
Quick self‑check: Keep a daily log of water intake, meals, and any uterine sensations; sharing this with your provider can highlight patterns you might miss on your own.
Special situations: twins, prior preterm birth, and maternal health conditions
Women carrying multiples (twins or more) naturally have a higher baseline risk of preterm labor. In these pregnancies, clinicians may use fFN testing more liberally, often starting earlier (around 20 weeks) if symptoms arise. A positive fFN in a twin pregnancy can indicate a risk as high as 30 % for delivery within two weeks, prompting earlier administration of steroids and closer surveillance.
If you’ve had a previous preterm birth, the fFN test becomes a valuable tool for early detection. Your provider may schedule regular symptom check‑ins and consider prophylactic measures—such as a weekly low‑dose aspirin regimen recommended by ACOG for women with a history of preterm delivery.
Chronic conditions like hypertension, diabetes, or autoimmune disorders can also affect fFN accuracy. For example, inflammation from an infection can cause a false‑positive result. In such cases, your provider may repeat the test after treating the underlying condition or rely more heavily on cervical length and clinical observation.
Regardless of the scenario, open communication with your care team is essential. Bring a written list of your medical history, medications, and any previous pregnancy outcomes to each visit, so the provider can interpret your fFN result in the correct context.
When to consider repeat fFN testing
If symptoms persist after an initial negative or borderline result, many clinicians recommend a repeat fFN test after 48–72 hours. A second negative test further lowers the short‑term risk, while a new positive result may signal a change in the uterine environment that warrants closer monitoring.
Guidelines from ACOG suggest that repeat testing should be reserved for women who continue to experience uterine tightening, pelvic pressure, or unexplained spotting, especially when cervical length remains short. The decision is always individualized, balancing the benefits of early detection with the cost and patient comfort.
Insurance, cost, and access considerations
In the United States, most private insurers and Medicaid cover the fFN test when it’s medically indicated, citing ACOG’s recommendation for symptomatic women. Out‑of‑pocket costs, when they occur, typically range from $50 to $150. In the UK, the NHS provides the test free of charge for eligible patients, though access may vary by region.
If cost is a concern, ask your provider whether the test can be bundled with other labs or if a hospital‑based rapid assay (often covered) is available. Some clinics also offer sliding‑scale fees or financial assistance programs. Knowing your insurance benefits ahead of time can prevent surprise bills and keep you focused on care.
Doctor's note
From our medical team: The fetal fibronectin test is a valuable risk‑stratification tool, but it’s only one piece of the puzzle. A positive result should prompt timely administration of steroids and close monitoring, while a negative result lets you breathe easier—but does not replace standard prenatal care. If you ever feel unsure about what your result means, ask your provider to explain the numbers, the next steps, and how they fit into your overall birth plan.
Myth vs. fact
Myth: A positive fFN test guarantees I will go into preterm labor.
Fact: A positive result indicates higher short‑term risk (about 15–20 % chance of delivery within 14 days), but most women with a positive test do not deliver early, especially when interventions are applied.
Myth: A negative fFN test means I’m completely out of danger for preterm birth.
Fact: A negative result is reassuring for the next two weeks, but you still need routine prenatal care and should watch for new symptoms.
Myth: The fFN test can replace cervical length ultrasound.
Fact: Both tests provide complementary information; when combined, they improve overall risk assessment more than either alone.
Key takeaways
Preterm labor is delivery before 37 weeks; it carries higher neonatal risks.
The fFN test detects a protein that appears when membranes start separating; a positive result raises short‑term risk.
A negative fFN result is highly reassuring for the next 14 days, but does not eliminate all preterm‑birth risk.
If your test is positive, expect steroids, possible tocolytics, and closer monitoring.
Maintain healthy habits—no smoking, balanced diet, stress management—to support pregnancy regardless of test outcome.
Always contact your provider if you notice new bleeding, fluid loss, severe cramping, or a change in fetal movement.
Frequently asked questions
What does a positive fFN test result mean?
A positive result means fetal fibronectin was detected at ≥ 50 ng/mL, indicating a higher likelihood (about 15–20 %) of delivering within the next two weeks. Your provider will likely start steroids, consider tocolytics, and increase monitoring frequency.
Can a negative fFN test result guarantee no preterm labor?
No. While a negative result carries a 98 % negative predictive value for delivery within 14 days, it does not rule out preterm birth later in pregnancy. Ongoing prenatal care remains essential.
How often should I get an fFN test during pregnancy?
The test is not a routine screening; it’s ordered when you have symptoms suggestive of preterm labor, typically between 22 and 34 weeks. Repeat testing may be done if the first result is borderline or if symptoms persist.
What are the risk factors for preterm labor?
Key risk factors include a prior preterm birth, multiple gestation, uterine or cervical abnormalities, infections, smoking, chronic hypertension, diabetes, and high maternal stress levels. Knowing these can help your provider tailor monitoring.
Can preterm labor be prevented with fFN test results?
The test itself doesn’t prevent labor, but a positive result prompts timely interventions—like corticosteroids and possible tocolytics—that can delay delivery and improve neonatal outcomes.
What are the next steps after a positive fFN test result?
Expect your provider to assess cervical length, administer antenatal steroids, discuss possible tocolytic medication, schedule more frequent visits, and reinforce lifestyle recommendations aimed at reducing further risk.
Can the fFN test be done at home?
Currently, the fFN test requires a clinician‑collected swab and a laboratory or point‑of‑care analyzer, so it isn’t available as a home‑based kit. Some research clinics are exploring self‑collection, but standard practice still calls for an in‑office visit.
What should I ask my provider at my next appointment after receiving results?
Consider asking: “How does my fFN result change my risk profile?”, “Should we schedule a cervical length ultrasound?”, “What are the plans for steroids or tocolytics if needed?”, and “What specific symptoms should prompt me to call you right away?” These questions help you stay informed and proactive.
Is the fFN test safe for the baby?
Yes. The test involves a gentle swab of the vaginal canal and does not expose the fetus to radiation or medication. Both ACOG and the NHS consider it safe for use at any gestational age within the recommended window.
Can recent intercourse affect the fFN result?
Sexual activity can introduce mucus or blood that may lead to a false‑positive result. Guidelines from RCOG advise abstaining from intercourse for at least 24 hours before the swab to reduce this risk.
When to call your doctor
If you experience any of the following, contact your obstetric provider immediately: sudden or persistent uterine contractions (more than four in an hour), vaginal bleeding or spotting, fluid leaking from the vagina, severe pelvic or lower‑back pain, or a noticeable decrease in fetal movement. This article is for informational purposes only and does not replace personalized medical advice.
References
American College of Obstetricians and Gynecologists (ACOG). “Management of Preterm Labor.” Practice Bulletin No. 171, 2016.
National Institute for Health and Care Excellence (NICE). “Preterm Labour and Birth.” Clinical Guideline CG136, 2019.
World Health Organization (WHO). “Preterm Birth.” Global Health Estimates, 2021.
Centers for Disease Control and Prevention (CDC). “Preterm Birth.” 2022 data brief.
Royal College of Obstetricians and Gynaecologists (RCOG). “Fetal Fibronectin Testing in Symptomatic Women.” Green‑top Guideline No. 77, 2020.
Mayo Clinic. “Fetal Fibronectin Test.” Patient education, accessed 2024.
Society for Maternal‑Fetal Medicine (SMFM). “Guidelines for the Use of Fetal Fibronectin.” 2023 update.
National Institutes of Health (NIH). “Cervical Length Measurement in Pregnancy.” Clinical Obstetrics Review, 2022.
British National Health Service (NHS). “Stress and Pregnancy.” Patient information, 2023.
American College of Obstetricians and Gynecologists (ACOG). “Aspirin Use to Prevent Preterm Birth.” Committee Opinion, 2020.
When Shubhra Mishra was expecting her first child in 2016, she was overwhelmed by conflicting food advice — one site said yes, another said never. By the time her second baby arrived in 2019, she realized millions of mothers face the same confusion.
That sparked a five-year journey through clinical nutrition papers, cultural diets, and expert conversations — all leading to BumpBites: a calm, compassionate space where science meets everyday motherhood.
Her long-term vision is to build a global community ensuring safe, supported, and free deliveriesfor every mother — because no woman should face pregnancy alone or uninformed. 🌿
🌍 Stand with mothers, shape safer guidance
Join a small circle of experts who review BumpBites articles so expecting parents everywhere can decide with confidence.
